MAVERIC: Midlands trial of amiodarone vs electrophysiology-guided interventions and cardio-defibrillator in ventricular arrhythmias.
Completed
- Conditions
- Cardiovascular diseases: Heart diseaseCirculatory SystemHeart disease
- Registration Number
- ISRCTN14274472
- Lead Sponsor
- Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 214
Inclusion Criteria
1. Patients who presented with sustained ventricular tachycardia (VT), ventricular fibrillation (VF) or sudden cardiac death (SCD) and survived to reach hospital within the Midlands from Feb 1997 to Jan 1999 were actively identified and entered into the study.
2. Patients who were not of child-bearing age or had a life-expectancy of <6 months from a non-arrhythmic cause were approached for entry into the trial.
Patients who were ineligible for or refused to join the trial were entered into the study's registry.
Exclusion Criteria
Does not match inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Death<br>2. Arrhythmia recurrence<br>3. Hospitalisation<br>4. Drug use<br>5. Quality of life<br>6. Cost of managing patients
- Secondary Outcome Measures
Name Time Method ot provided at time of registration